Viewing nowCombinationOlmedica HCT Tablet 10/40/12.5 mg
Olmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg +1 more
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.

MFDS item code 201903060 · Approved 2019.05.10 · Insurance code 649605040
Improvement in blood pressure control for essential hypertension
The combination therapy of Amlodipine and Olmesartan Medoxomil is used when blood pressure is not adequately controlled in patients with essential hypertension. These two drugs work through different mechanisms to dilate blood vessels and lower blood pressure. Amlodipine, a calcium channel blocker, relaxes vascular smooth muscle to reduce blood pressure, while Olmesartan Medoxomil, an angiotensin II receptor blocker, prevents vascular constriction and aids in blood pressure control. Proper blood pressure control can reduce the risk of cardiovascular complications. This combination therapy effectively improves hypertension.
Take one tablet once a day with water, regardless of meals. It is recommended to take it at the same time every day (e.g., morning). The maximum dose is Amlodipine/Olmesartan Medoxomil/Hydrochlorothiazide 10/40/25 mg. Adjust the dosage after an interval of more than 2 weeks considering blood pressure response. Recommended dosage steps: - 5/20/12.5 mg - 5/40/12.5 mg -
Safety and efficacy in pediatric patients under 18 years have not been established, and administration of this medication is not recommended.
This medication should not be taken during the second and third trimesters of pregnancy as it can cause serious harm to the fetus and newborn. If pregnancy is confirmed, the medication should be discontinued immediately. Individuals allergic to this medication or similar drugs should not use it. Patients with severe hypotension, significant issues with the heart, kidneys, or liver should also avoid this medication. It should be avoided in patients with unstable heart failure or shock after acute myocardial infarction. Patients with reduced blood volume or electrolyte imbalance may experience hypotension, so careful monitoring is required. Patients with impaired kidney function should regularly undergo blood tests to monitor renal function and electrolyte status. This medication is not recommended for patients with compromised liver function or progressive liver disease. Caution should be exercised in patients with specific heart valve diseases or obstructive cardiomyopathy. Due to the blood pressure-lowering effects of this medication, dizziness or drowsiness may occur, so caution should be taken when driving or operating hazardous machinery. This medication may interact with other drugs, so it is essential to inform the doctor or pharmacist of any other medications being taken, especially lithium, non-steroidal anti-inflammatory drugs, or other antihypertensive agents. This medication is not recommended for breastfeeding women, and if breastfeeding is to continue, consultation with a doctor is necessary. It is best not to use this medication in children under 18 years of age as safety and efficacy have not been established. In elderly patients, dosing should start at a low dose considering possible liver and kidney function decline and require careful monitoring. In cases of overdose, severe hypotension and arrhythmias may occur, necessitating immediate medical treatment. This medication should be stored away from direct sunlight and moisture, out of reach of children. Any unusual symptoms such as skin rash, breathing difficulties, or severe swelling during use should prompt immediate medical attention.
Urticaria, severe swelling (edema), difficulty breathing, jaundice (liver dysfunction), acute renal failure, acute respiratory distress syndrome (ARDS), pulmonary edema, Stevens-Johnson syndrome, thrombosis, embolism, Quincke's edema, myocardial infarction, seizures, severe allergic reactions, severe dermatological reactions, serious neurological symptoms, and severe swelling or urination abnormalities.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. Additionally, it is best to store it at room temperature between 1 and 30 degrees Celsius.
Round film-coated tablet in reddish-gray
30 tablets (10 tablets/Alu-Alu × 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg +1 more
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg +1 more
Tablet · Prescription medication · Combination
Daicel Corporation (Co., Ltd.)
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
HanKook Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 20mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corporation
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.